{
  "ticker": "ROG.SW",
  "company": "Roche Holding AG",
  "sector": "Healthcare",
  "recommendation": "BUY",
  "confidence_score": 0.72,
  "key_drivers": [
    "Strong uptrend momentum from November 2025 onwards",
    "Attractive dividend yield of 2.83%",
    "Solid market position in pharmaceutical sector",
    "Recent price recovery near 52-week highs",
    "Large-cap stability with CHF 272B market cap"
  ],
  "risks": [
    "Elevated PE ratio of 28.85 suggests premium valuation",
    "Significant volatility observed in mid-2025 (April-August weakness)",
    "Regulatory and patent expiration risks in drug manufacturing",
    "Macroeconomic sensitivity in healthcare sector",
    "Concentration risk in pharmaceutical pipeline"
  ],
  "technical_view": "Strong bullish momentum with price appreciating 46% from 52-week low (231.9 CHF) to current level (339.0 CHF). Notable recovery pattern from April-August 2025 weakness, followed by sustained uptrend from November 2025. Price now trading near 52-week high (342.9 CHF), indicating strong technical strength. Weekly closes show consistent higher lows and higher highs since November, suggesting institutional accumulation. Current price at 339.0 CHF represents 99% of 52-week high, indicating potential resistance near 342.9 CHF level.",
  "metrics": {
    "market_cap": 271964323840.0,
    "pe_ratio": 28.851065,
    "peg_ratio": null,
    "dividend_yield": 2.83,
    "eps": null,
    "profit_margin": null,
    "high_52_week": 342.9,
    "low_52_week": 231.9,
    "analyst_target_price": null,
    "currency": "CHF"
  }
}